X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Wockhardt Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Quarterly Results   (WOCK)

Here are the latest quarterly results of Wockhardt. For more details, see the Wockhardt financial fact sheet and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Wockhardt Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m10,6479,9568,6358,91110,22310,05310,18310,077 
Other income Rs m19953563370546371-8474 
Turnover Rs m10,84610,0089,1989,28110,76810,42410,09910,151 
Expenses Rs m9,6529,77410,2789,51110,0109,58610,24410,033 
Gross profit Rs m9161,770-1,318-4,183213467-45133 
Depreciation Rs m374381371372362380382392 
Interest Rs m564614589611676618650727 
Profit before tax Rs m178827-1,715-4,795-279-160-1,160-911 
Tax Rs m8-15733-170-191265352-49 
Profit after tax Rs m170984-1,747-4,626-88-426-1,513-862 
Gross profit margin %8.617.8-15.3-46.92.14.6-0.41.3 
Effective tax rate %4.3-19.0-1.93.568.4-165.8-30.45.4 
Net profit margin %1.69.9-20.2-51.9-0.9-4.2-14.9-8.6 
Diluted EPS Rs 1.5 8.9 -15.9 -42.0 -0.8 -3.9 -13.7 -7.8  
Diluted EPS (TTM) Rs 12.4 15.8 -3.9 -47.4 -49.8 -62.6 -60.5 -26.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Wockhardt 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DISHMAN PHARMA  AUROBINDO PHARMA  UNICHEM LAB  FDC LTD.  ASTRAZENECA PHARMA  

Compare WOCKHARDT LTD. With:   DISHMAN PHARMA  AUROBINDO PHARMA  UNICHEM LAB  FDC LTD.  ASTRAZENECA PHARMA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 297 Points Higher; Energy and Realty Stocks Witness Buying(Closing)

Share markets in India continued their momentum during closing hours and ended the day on a positive note. Sectoral indices were trading on a positive note, with stocks in the energy sector.

Views on news

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (4QFY18); Net Profit Down 13.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, WOCKHARDT LTD. has posted a net profit of Rs 2 bn (down 13.4% YoY). Sales on the other hand came in at Rs 10 bn (up 17.9% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Oct 16, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - SHASUN PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS